Impact of coating particles on liquid marble lifetime: reactor engineering approach to evaporation

Liquid marbles are soft matter objects characterised by a liquid droplet enclosed within a hydrophobic particle coating, preventing wetting. This distinctive structure serves as active sites for solid-liquid-gas reactions. However, the impact the chosen coating material has on liquid marble stability, particularly regarding the number of coating layers and material wetting, remains uncertain. There is a need for a modelling approach to predict the overall lifetime considering these coating characteristics. This study reveals that for PTFE liquid marbles evaporating at ambient temperature, smaller coating particles (250 nm) extend their lifetime by forming a multilayered coating. Conversely, using larger particle sizes (200 μm) results in the formation of monolayer liquid marbles with shorter lifetimes than their equivalent naked droplets. Additionally, a higher number of particle layers and a larger contact angle generally enhance the liquid marble\u27s lifetime. For multilayered liquid marbles comprised of smaller particles (250 nm), the particle contact angle is found to have a more significant impact than the number of layers on lifetime extension, whereas the opposite holds true for larger particle sizes (20 μm). A modelling approach using the reactor engineering method for liquid marble evaporation demonstrates excellent agreement with experimental results, yielding an R2 of 0.996. The implementation of this specific model, capable of assessing lifetime across various physical modifications, will enhance our understanding of liquid marble properties before their application in biomedical, microreactor, and green technologies

Overlap, common features, and essential differences in pediatric granulomatous inflammatory bowel disease.

Contains fulltext : 89868.pdf (publisher's version ) (Closed access)Overlap in the clinical presentation of pediatric granulomatous inflammatory bowel disease may be substantial, depending on the mode of presentation. Chronic granulomatous disease (CGD) may present with granulomatous colitis, perianal abscesses, hepatic abscesses or granulomas, failure to thrive, and obstruction of the gastrointestinal tract (including esophageal strictures and dysmotility, delayed gastric emptying, and small bowel obstruction). Anemia, thrombocytosis, elevated C-reactive protein and erythrocyte sedimentation rate, and hypoalbuminemia are nonspecific and may occur in any of the granulomatous inflammatory bowel diseases. In histology, macrophages with cytoplasmic inclusions will be rather specific for CGD. Sarcoidosis may present with abdominal pain or discomfort, diarrhea, weight loss, growth failure, delayed puberty, erythema nodosum, arthritis, uveitis, and hepatic granulomata. Only in 55% of the patients will angiotensin-converting enzyme be elevated. The noncaseating epithelioid granulomata will be unspecific. Bronchoalveolar lymphocytosis and abnormalities in pulmonary function are reported in sarcoidosis and in Crohn disease (CD) and CGD. Importantly, patients with CD may present with granulomatous lung disease, fibrosing alveolitis, and drug-induced pneumonitis. Sarcoidosis and concomitant gastrointestinal CD have been reported in patients, as well as coexistence of CD and sarcoidosis in siblings. Common susceptibility loci have been identified in CD and sarcoidosis. CD and CGD share defects in the defense mechanisms against different microbes. In the present review, common features and essential differences are discussed in clinical presentation and diagnostics--including histology--in CGD, sarcoidosis, and CD, together with 2 other granulomatous inflammatory bowel diseases, namely abdominal tuberculosis and Hermansky-Pudlak syndrome. Instructions for specific diagnosis and respective treatments are provided.1 december 201